Cargando…
Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver
BACKGROUND: Mice with humanized livers are important models to study drug toxicology testing, development of hepatitis virus treatments, and hepatocyte transplantation therapy. However, the huge difference between mouse and human in size and anatomy limited the application of humanized mice in inves...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900390/ https://www.ncbi.nlm.nih.gov/pubmed/35255981 http://dx.doi.org/10.1186/s13578-022-00760-3 |
_version_ | 1784664102698745856 |
---|---|
author | Ren, Jilong Yu, Dawei Wang, Jing Xu, Kai Xu, Yanan Sun, Renren An, Peipei Li, Chongyang Feng, Guihai Zhang, Ying Dai, Xiangpeng Zhao, Hongye Wang, Zhengzhu Han, Zhiqiang Zhu, Haibo Ding, Yuchun You, Xiaoyan Liu, Xueqin Wu, Meng Luo, Lin Li, Ziyi Yang, Yong-Guang Hu, Zheng Wei, Hong-jiang Ge, Liangpeng Hai, Tang Li, Wei |
author_facet | Ren, Jilong Yu, Dawei Wang, Jing Xu, Kai Xu, Yanan Sun, Renren An, Peipei Li, Chongyang Feng, Guihai Zhang, Ying Dai, Xiangpeng Zhao, Hongye Wang, Zhengzhu Han, Zhiqiang Zhu, Haibo Ding, Yuchun You, Xiaoyan Liu, Xueqin Wu, Meng Luo, Lin Li, Ziyi Yang, Yong-Guang Hu, Zheng Wei, Hong-jiang Ge, Liangpeng Hai, Tang Li, Wei |
author_sort | Ren, Jilong |
collection | PubMed |
description | BACKGROUND: Mice with humanized livers are important models to study drug toxicology testing, development of hepatitis virus treatments, and hepatocyte transplantation therapy. However, the huge difference between mouse and human in size and anatomy limited the application of humanized mice in investigating human diseases. Therefore, it is urgent to construct humanized livers in pigs to precisely investigate hepatocyte regeneration and human hepatocyte therapy. CRISPR/Cas9 system and somatic cell cloning technology were used to generate two pig models with FAH deficiency and exhibiting severe immunodeficiency (FAH/RAG1 and FAH/RAG1/IL2RG deficiency). Human primary hepatocytes were then successfully transplanted into the FG pig model and constructed two pigs with human liver. RESULTS: The constructed FAH/RAG1/IL2RG triple-knockout pig models were characterized by chronic liver injury and severe immunodeficiency. Importantly, the FG pigs transplanted with primary human hepatocytes produced human albumin in a time dependent manner as early as 1 week after transplantation. Furthermore, the colonization of human hepatocytes was confirmed by immunochemistry staining. CONCLUSIONS: We successfully generated pig models with severe immunodeficiency that could construct human liver tissues. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-022-00760-3. |
format | Online Article Text |
id | pubmed-8900390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89003902022-03-17 Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver Ren, Jilong Yu, Dawei Wang, Jing Xu, Kai Xu, Yanan Sun, Renren An, Peipei Li, Chongyang Feng, Guihai Zhang, Ying Dai, Xiangpeng Zhao, Hongye Wang, Zhengzhu Han, Zhiqiang Zhu, Haibo Ding, Yuchun You, Xiaoyan Liu, Xueqin Wu, Meng Luo, Lin Li, Ziyi Yang, Yong-Guang Hu, Zheng Wei, Hong-jiang Ge, Liangpeng Hai, Tang Li, Wei Cell Biosci Research BACKGROUND: Mice with humanized livers are important models to study drug toxicology testing, development of hepatitis virus treatments, and hepatocyte transplantation therapy. However, the huge difference between mouse and human in size and anatomy limited the application of humanized mice in investigating human diseases. Therefore, it is urgent to construct humanized livers in pigs to precisely investigate hepatocyte regeneration and human hepatocyte therapy. CRISPR/Cas9 system and somatic cell cloning technology were used to generate two pig models with FAH deficiency and exhibiting severe immunodeficiency (FAH/RAG1 and FAH/RAG1/IL2RG deficiency). Human primary hepatocytes were then successfully transplanted into the FG pig model and constructed two pigs with human liver. RESULTS: The constructed FAH/RAG1/IL2RG triple-knockout pig models were characterized by chronic liver injury and severe immunodeficiency. Importantly, the FG pigs transplanted with primary human hepatocytes produced human albumin in a time dependent manner as early as 1 week after transplantation. Furthermore, the colonization of human hepatocytes was confirmed by immunochemistry staining. CONCLUSIONS: We successfully generated pig models with severe immunodeficiency that could construct human liver tissues. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-022-00760-3. BioMed Central 2022-03-07 /pmc/articles/PMC8900390/ /pubmed/35255981 http://dx.doi.org/10.1186/s13578-022-00760-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ren, Jilong Yu, Dawei Wang, Jing Xu, Kai Xu, Yanan Sun, Renren An, Peipei Li, Chongyang Feng, Guihai Zhang, Ying Dai, Xiangpeng Zhao, Hongye Wang, Zhengzhu Han, Zhiqiang Zhu, Haibo Ding, Yuchun You, Xiaoyan Liu, Xueqin Wu, Meng Luo, Lin Li, Ziyi Yang, Yong-Guang Hu, Zheng Wei, Hong-jiang Ge, Liangpeng Hai, Tang Li, Wei Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver |
title | Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver |
title_full | Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver |
title_fullStr | Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver |
title_full_unstemmed | Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver |
title_short | Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver |
title_sort | generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900390/ https://www.ncbi.nlm.nih.gov/pubmed/35255981 http://dx.doi.org/10.1186/s13578-022-00760-3 |
work_keys_str_mv | AT renjilong generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT yudawei generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT wangjing generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT xukai generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT xuyanan generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT sunrenren generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT anpeipei generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT lichongyang generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT fengguihai generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT zhangying generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT daixiangpeng generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT zhaohongye generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT wangzhengzhu generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT hanzhiqiang generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT zhuhaibo generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT dingyuchun generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT youxiaoyan generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT liuxueqin generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT wumeng generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT luolin generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT liziyi generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT yangyongguang generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT huzheng generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT weihongjiang generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT geliangpeng generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT haitang generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver AT liwei generationofimmunodeficientpigwithhereditarytyrosinemiatype1andtheirpreliminaryapplicationforhumanizedliver |